New Blood Biomarker Identifies Status of Fatty Liver Disease
A specific subtype of macrophages in progressive NAFLD serve as useful biomarkers of liver disease progression.
Read MorePosted by Andy Lundin | Jun 22, 2022 | Diabetes & Metabolic Diseases |
A specific subtype of macrophages in progressive NAFLD serve as useful biomarkers of liver disease progression.
Read MorePosted by Andy Lundin | Jun 16, 2022 | Diabetes & Metabolic Diseases |
A new test could more accurately predict if individuals who undergo gastric bypass surgery will experience a remission of type 2 diabetes.
Read MorePosted by Andy Lundin | Jun 6, 2022 | Diabetes & Metabolic Diseases |
Abbott is developing a new biowearable that will continuously monitor glucose and ketone levels in one sensor.
Read MorePosted by Andy Lundin | Jun 3, 2022 | Diabetes & Metabolic Diseases |
Blood-based tests can be useful for initial diagnosis of liver disorders. Imaging methods are more accurate in assessing disorders severity.
Read MorePosted by Andy Lundin | May 31, 2022 | Kidney Disease |
Researchers established the inherited condition, TULP3-related ciliopathy, which causes kidney and liver failure in children and adults.
Read More